Clinical Trial

The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes

Study acronym: DIPAR RCT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Digital health tools may present an opportunity to address these challenges by enhancing care delivery, improving patient engagement, and facilitating better disease management for chronic diseases such as type 2 diabetes mellitus (T2DM). This primary objective of this randomized controlled trial is to evaluate whether the Diabetes Digital Patient Reminder (DIPAR), embedded in patient portal, can increase the proportion of T2DM patients who have their albuminuria measured at least once annually by either a general practitioner (GP) or a diabetes specialist, as documented in their hospital medical records (EMD), thereby reflecting active monitoring of diabetes-related parameters.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-26.
Status change: Recruiting → Active, Not Recruiting 2026-02-18
Trial Details
NCT Number NCT07257822
Lead Sponsor KU Leuven
Collaborators: Regionaal Ziekenhuis Heilig Hart Tienen, Universitaire Ziekenhuizen KU Leuven
Conditions Type 2 Diabetes Mellitus (T2DM)
Enrollment 200 participants
Start Date 2025-10-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-19